Work

Supplementary Figure S3 from Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

Year: 2025

Type: supplementary-materials

Abstract: Pharmacokinetic profile of TL-895 in C57BL/6 and NSG mice. TL-895 plasma concentrations were determined in male and female mice on a C57BL/6 (A) or NSG (B) background strain. Mice received a single oral dose of 3 or 10 mg/kg. Data represent mean values (symbols) and SD (error bars) using 5 animals per group.

DOI: 10.1158/2767-9764.30111359

Authors: Jack C. Stromatt, Eman A. Ahmed, Thomas Drabison, Mahesh R. Nepal, Anika T. Chowdhury, Shelley J. Orwick, Daelynn R. Buelow, Eric D. Eisenmann, Kevin M. Huang, Alex Sparreboom, Sharyn D. Baker

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4414164179

Cites:

Cited by:

Related to: